Motion sickness
Conditions
Interventions
Experimental group:Baoji Tablets and Baoji Pills placebo
Positive control group:Baoji Pills and Baoji Tablets placebo
Placebo-control group:Baoji Pills placebo and Baoji Tablets placebo
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Conform to the standard of Motion sickness; (2) Conform to the standard of turbid dampness stagnation syndrome of TCM; (3) Aged 18-50 years; (4) Subjects signed written informed consent.
Exclusion criteria
Exclusion criteria: (1) Serious primary diseases of heart, liver, kidney and blood system or endocrine system, tumor or HIV; (2) ALT 1.5 times the upper limit of normal reference values; abnormal blood creatinine; blood WBC 10.0*10^9/L and/or neutrophil differential count >80%; (3) Pregnancy or for pregnant women, women in lactation period; (4) Atopy or allergic to this medicine; (5) Mental or legally disabled patients; (6) Participanting in other drug clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motion sickness incidence;Motion sickness incidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of Classification and grading of symptoms;TCM syndrome severity proportion;The incidence of turbid dampness stagnation syndrom; | — |
Countries
China
Contacts
Public ContactLi Ning
Outcome results
None listed